Catecholamines relax detrusor through β2-adrenoceptors in mouse and β3-adrenoceptors in man

Journal of Pharmacology and Experimental Therapeutics

Volumn 328, Issue 1, 2009, Pages 213-222

  Wuest, Melinda ^a   Eichhorn, Birgit ^a   Grimm, Marc O ^a   Wirth, Manfred P ^a   Ravens, Ursula ^a   Kaumann, Alberto J ^b  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; BETA 3 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; CARBACHOL; ISOPRENALINE; L 748337; M [4 [2 [3 [3 (ACETAMIDOMETHYL)PHENOXY] 2 HYDROXYPROPYL]AMINO]ETHYL]PHENYLBENZSULFONAMIDE; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG; ADRENALIN; BETA 2 ADRENERGIC RECEPTOR; CATECHOLAMINE; CAVEOLIN 1; MESSENGER RNA; PRIMER DNA;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAVEOLA; CELL MEMBRANE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DETRUSOR DYSSYNERGIA; DETRUSOR MUSCLE; DRUG ANTAGONISM; DRUG POTENTIATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; WILD TYPE; ANIMAL; BLADDER; C57BL MOUSE; DRUG EFFECT; GENETICS; MIDDLE AGED; MOUSE MUTANT; MUCOSA; MUSCLE CONTRACTION; MUSCLE RELAXATION; PHYSIOLOGY; POLYMERASE CHAIN REACTION; SKELETAL MUSCLE;

AGED; ANIMALS; CATECHOLAMINES; CAVEOLIN 1; DNA PRIMERS; EPINEPHRINE; FEMALE; HUMANS; ISOPROTERENOL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; MUCOUS MEMBRANE; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE, SKELETAL; POLYMERASE CHAIN REACTION; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, ADRENERGIC, BETA-3; RNA, MESSENGER; URINARY BLADDER;

EID: 59149087619     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.108.142562     Document Type: Article

References (41)

1. Andersson KE (2004) New pharmacologic targets for the treatment of the overactive bladder: an update. Urology 63:32-41.
2. Andersson KE and Arner A (2004) Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiol Rev 84:935-986.
3. Arunlakshana O and Schild HO (1959) Some quantitative uses of drug antagonism. Br J Pharmacol 14:48-58.
4. Candelore MR, Deng L, Tota L, Guan XM, Amend A, Liu Y, Newbold R, Cascieri MA, and Weber AE (1999) Potent and selective human β-adrenergic receptor antagonists. J Pharmacol Exp Ther 290:649-655.
5. Chernogubova E, Hutchinson DS, Nedergaard J, and Bengtsson T (2005) Alphal-and beta1-adrenoceptor signaling fully compensated for adrenoceptor deficiency in brown adipocyte norepinephrine-stimulated glucose uptake. Endocrinology 146: 2271-2284.
6. Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, Menne J, Lindschau C, Mende F, Luft FC, et al. (2001) Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293:2449 -2452.
7. 2 muscarinic receptor to oppose the relaxant effect of isoproterenol on cholinergic contractions in mouse urinary bladder. J Pharmacol Exp Ther 322:631-637.
8. El-Yazbi AF, Cho WJ, Schulz R, and Daniel EE (2006) Caveolin-1 knockout alters ( -adrenoceptors function in mouse small intestine. Am J Physiol Gastrointest Liver Physiol 291:G1020 -G1030.
9. Evans BA, Papaioannou M, Hamilton S, and Summers RJ (1999) Alternative splicing generates two isoforms of the beta3-adrenoceptor which are differently expressed in mouse tissues. Br J Pharmacol 127:1525-1531.
10. Hoffmann C, Leitz MR, Oberdorf-Maass S, Lohse MJ, and Klotz KN (2004) Comparative pharmacology of human β-adrenergic receptor subtypes: characterization of stably transfected receptors in CHO cells. Naunyn Schmiedebergs Arch Pharmacol 369: 151-159.
11. 3-adrenoceptor-mediated relaxation of the human detrusor. Acta Physiol Scand 164:117-118.
12. 3-adrenoceptor in the human detrusor muscle. Br J Pharmacol 126:819-825.
13. Igawa Y, Yamazaki Y, Takeda H, Kaidoh K, Akahane M, Ajisawa Y, Yoneyama T, Nishizawa O, and Andersson KE (2001) Relaxant effects of isoproterenol and selective ( 3-adrenoceptor agonists on normal, low compliant and hyperreflexic human bladders. J Urol 165:240-244.
14. Insel PA, Head BP, Patel HH, Roth DM, Bundey RA, and Swaney JS (2005) Compartmentation of G-protein-coupled receptors and their signalling components in lipid rafts and caveolae. Biochem Soc Trans 33: 1131-1134.
15. Insel PA and Patel HH (2007) Do studies in caveolin-knockouts teach us about physiology and pharmacology or instead, the ways mice compensate for "lost proteins"? Br J Pharmacol 150:251-254.
16. 2-adrenoceptor-mediated positive inotropic
17. effect of adrenaline in human ventricular myocardium: quantitative discrepancies with binding and adenylate cyclase stimulation. Naunyn Schmiedebergs Arch Pharmacol 335:403-411.
18. Lai HH, Boone TB, Thompson TC, Smith CP, and Somogyi GT (2007) Using caveolin-1 knockout mouse to study impaired detrusor contractility and disrupted muscarinic activity in the aging bladder. Urology 69:407-411.
19. Lai HH, Boone TB, Yang G, Smith CP, Kiss S, Thompson TC, and Somogyi GT (2004) Loss of caveolin-1 expression is associated with disruption of muscarinic cholinergic activities in the urinary bladder. Neurochem Int 45:1185-1193.
20. Lemoine H, Ehle B, and Kaumann AJ (1985) Direct labelling of beta 2-adrenoceptors: comparison of binding potency of 3H-ICI 118,551 and blocking potency of ICI 118,551. Naunyn Schmiedebergs Arch Pharmacol 331:40-51.
21. Longhurst PA and Levendusky M (1999) Pharmacological characterization of beta- adrenoceptors mediating relaxation of the rat urinary bladder in vitro. Br J Pharmacol 127:1744-1750.
22. 3-adrenoceptor-mediated relaxation of the female rat detrusor muscle. Urology 59:621-625.
23. Matsui M, Griffin MT, Shehnaz D, Taketo MM, and Ehlert FJ (2003) Increased relaxant action of forskolin and isoproterenol against muscarinic agonist-induced contractions in smooth muscle from M2 receptor knockout mice. J Pharmacol Exp Ther 305:106-113.
24. 3-adrenoceptors in the urinary bladder, urethra and prostate. Br J Pharmacol 147 (Suppl 2):S88-S119.
25. Morita T, Iizuka H, Iwata T, and Kondo S (2000) Function and distribution of beta3-adrenoceptors in rat, rabbit and human urinary bladder and external urethral sphincter. J Smooth Muscle Res 36:21-32.
26. Neidhold S, Eichhorn B, Kasper M, Ravens U, and Kaumann AJ (2007) The function of α- and (β-adrenoceptors of the saphenous artery in caveolin-1 knockout and wild-type mice. Br J Pharmacol 150:261-270.
27. Nomiya M and Yamaguchi O (2003) A quantitative analysis of mRNA expression of alpha 1 and beta-adrenoceptor subtypes and their functional roles in human normal and obstructed bladders. J Urol 170:649 -653.
28. Oshita M, Hiraoka Y, and Watanabe Y (1997) Characterization of beta- adrenoceptors in urinary bladder: comparison between rat and rabbit. Br J Pharmacol 122:1720-1724.
29. Ostrom RS and Insel PA (2004) The evolving role of lipid rafts and caveolae in g protein-coupled receptor signaling: implications for molecular pharmacology. Br J Pharmacol 143:235-245.
30. Ostrom RS, Violin JD, Coleman S, and Insel PA (2000) Selective enhancement of beta-adrenergic receptor signaling by overexpression of adenylyl cyclase type 6: colocalization of receptor and adenylyl cyclase in caveolae of cardiac myocytes. Mol Pharmacol 57:1075-1079.
31. Razani B, Woodman SE, and Lisanti MP (2002) Caveolae: from cell biology to nimal physiology. Pharmacol Rev 54:431-467.
32. Rybin VO, Xu X, Lisanti MP, and Steinberg SF (2000) Differential targeting of beta-adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae: a mechanism to functionally regulate the cAMP signaling pathway. J Biol Chem 275:41447-41457.
33. Schwencke C, Okumura S, Yamamoto M, Geng YJ, and Ishikawa Y (1999) Colocalization of beta-adrenergic receptors and caveolin within the plasma membrane. J Cell Biochem 75:64-72.
34. Takeda H, Matsuzawa A, Igawa Y, Yamazaki Y, Kaidoh K, Akahane S, Kojima M, Miyata H, Akahane M, and Nishizawa O (2003) Functional characterization of beta-adrenoceptor subtypes in the canine and rat lower urinary tract. J Urol 170:654-658.
35. 3-adrenoceptor subtypes in relaxation of the human urinary bladder detrusor: analysis by molecular biological and pharmacological methods. J Pharmacol Exp Ther 288:1367-1373.
36. Uchida H, Shishido K, Nomiya M, and Yamaguchi O (2005) Involvement of cyclic AMP-dependent and -independent mechanisms in the relaxation of rat detrusor muscle via beta-adrenoceptors. Eur J Pharmacol 518:195-202.
37. Woodman SE, Cheung MW, Tarr M, North AC, Schubert W, Lagaud G, Marks CB, Russell RG, Hassan GS, Factor SM, et al. (2004) Urogenital alterations in aged male caveolin-1 knockout mice. J Urol 171:950-957.
38. Wuest M, Hecht J, Christ T, Braeter M, Schoeberl C, Hakenberg OW, Wirth MP, and Ravens U (2005) Pharmacodynamics of propiverine and three of its main metabolites on detrusor contraction. Br J Pharmacol 145:608-619.
39. Yamanishi T, Chapple CR, Yasuda K, Yoshida K, and Chess-Williams R (2002) Identification of beta-adrenoceptor subtypes in lower urinary tract of the female pig. J Urol 168:2706-2710.
40. Yamanishi T, Yasuda K, Kitahara S, Nakai H, Yoshida K, and Iizuka H (2006) Effects of 138 -355, a beta3-adrenoceptor selective agonist, on relaxation of the human detrusor muscle in vitro. Neurourol Urodyn 25:815-819.
41. Yamazaki Y, Takeda H, Akahane M, Igawa Y, Nishizawa O, and Ajisawa Y (1998) Species differences in the distribution of beta-adrenoceptor subtypes in bladder smooth muscle. Br J Pharmacol 124:593-599.